Basit öğe kaydını göster

dc.contributor.authorCamcioglu, Yildiz
dc.contributor.authorÖZKAN, Sengul
dc.contributor.authorOksuz, LÜTFİYE
dc.contributor.authorOzturk, Candan
dc.contributor.authorSalman, Nuran
dc.contributor.authorGurler, Nezahat
dc.contributor.authorKeser, Melike
dc.contributor.authorAlhan, Emre
dc.contributor.authorEsel, Duygu
dc.contributor.authorGultekin, Meral
dc.contributor.authorGul, Mustafa
dc.contributor.authorSORGUC, Yelda
dc.contributor.authorAydemir, Sohret
dc.contributor.authorGunaydin, Murat
dc.contributor.authorYAKUPOGULLARI, Yusuf
dc.contributor.authorKizirgil, Ahmet
dc.contributor.authorCEYHAN, MEHMET
dc.contributor.authorYAMAN, AKGÜN
dc.date.accessioned2021-03-03T18:45:46Z
dc.date.available2021-03-03T18:45:46Z
dc.date.issued2011
dc.identifier.citationCEYHAN M., Gurler N., YAMAN A., Ozturk C., Oksuz L., ÖZKAN S., Keser M., Salman N., Alhan E., Esel D., et al., "Serotypes of Streptococcus pneumoniae Isolates from Children with Invasive Pneumococcal Disease in Turkey: Baseline Evaluation of the Introduction of the Pneumococcal Conjugate Vaccine Nationwide", CLINICAL AND VACCINE IMMUNOLOGY, cilt.18, sa.6, ss.1028-1030, 2011
dc.identifier.issn1556-6811
dc.identifier.otherav_50daa0f3-666c-4f69-b3e9-23b59bcbc16e
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/57535
dc.identifier.urihttps://doi.org/10.1128/cvi.00526-10
dc.description.abstractBefore use of the pneumococcal conjugate vaccine PCV7 became widespread in Turkey, 202 invasive pneumococcus isolates were analyzed. The most common serotypes were 19F and 6B. In children <= 2 years of age, the potential coverage rate of PCV7 was 69.5%. The most frequent non-PCV7 serotypes were 19A, 3, 1, 6A, and 8.
dc.language.isoeng
dc.subjectMikrobiyoloji
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectBULAŞICI HASTALIKLAR
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectİmmünoloji
dc.titleSerotypes of Streptococcus pneumoniae Isolates from Children with Invasive Pneumococcal Disease in Turkey: Baseline Evaluation of the Introduction of the Pneumococcal Conjugate Vaccine Nationwide
dc.typeMakale
dc.relation.journalCLINICAL AND VACCINE IMMUNOLOGY
dc.contributor.departmentSelçuk Üniversitesi , ,
dc.identifier.volume18
dc.identifier.issue6
dc.identifier.startpage1028
dc.identifier.endpage1030
dc.contributor.firstauthorID92933


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster